Skip to main content
SpringerLink
Log in

Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Malignant hyperthermia (MH) is a rare clinical syndrome, triggered in susceptible subjects by a variety of anaesthetic agents and muscle relaxants, and is the commonest cause of death due to general anaesthesia. Previous studies have reported that inherited mutations in the ryanodine receptor (RYR1) gene co-segregated, in some families, with MH susceptibility; lack of linkage between MH and theRYR1 gene in some other families indicates a heterogenous genetic basis for the syndrome. The in vitro contracture test (IVCT) on muscle biopsy specimens is considered to be the most reliable test for establishing the diagnosis of MH. With the identification ofRYR1 point mutations this might in turn result in non-invasive methods for the presymptomatic diagnosis of MH. In the present study we investigated four families suspected to be at risk of MH susceptibility; in all subjects histopathological examination and IVCT were performed on muscle biopsy specimens. We undertook a mutation analysis ofRYR1 gene testing for the presence of five point mutations; in one pedigree a C1840 → T point mutation was detected, strictly segregating with in vitro MH susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Angelini C, Freddo L, Battistella P, Bresolin N, Pierobon-Bormioli S, Armani M, Vergani L (1981) Carnitine palmityl transferase deficiency: clinical variability, carrier detection and sutosomal recessive inheritance. Neurology 31:883–886

    Google Scholar 

  2. Ball SP, Johnson KJ (1993) The genetics of malignant hyperthermia. J Med Genet 30:89–93

    Google Scholar 

  3. Ball SP, Dorkins HR, Ellis FR, Hall JL, Halsall PJ, Hopkins PM, Mueller RF, Stewart AD (1993) Genetic linkage analysis of chromosome 19 markers in malignant hyperthermia. Br J Anaesth 70:70–75

    Google Scholar 

  4. Bresolin N, Zeviani M, Bonilla E, Miller RH, Leech RW, Shanske S, Nakagawa M, DiMauro S (1985) Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology 35:802–812

    Google Scholar 

  5. Bush A, Dubowitz V (1991) Fatal rhabdomyolysis complicating general anaesthesia in a child with Becker muscular dystrophy. Neuromusc Disord 3:201–204

    Google Scholar 

  6. Deufel T, Golla A, Iles D, Meindl A, Meitinger T, Schindelhauer D, DeVries A, Pongratz D, MacLennan DH, Johnson KJ, Lehmann-Horn F (1992) Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet 50:1151–1161

    Google Scholar 

  7. Deufel T, Muller-Felber W, Pongratz DE, Hubner G, Johnson K, Iaizzo PA, Lehmann-Horn F (1992) Chronic myopathy in a patient suspected of carrying two malignant hyperthermia susceptibility (MHS) mutations. Neuromusc Disord 2:389–396

    Google Scholar 

  8. DiMauro S, Miranda A, Olarte M, Friedman R, Hays AP (1982) Muscle phosphoglycerate mutase deficiency. Neurology; 32:584–591

    Google Scholar 

  9. Dubowitz V (1985) Muscle biopsy: a practical approach, 2nd edn. Bailliere Tindall, London

    Google Scholar 

  10. Ellis FR, Halsall PJ, Christian AS (1990) Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands. Anaesthesia 45:838–841

    Google Scholar 

  11. European Malignant Hyperthemia Group (1984) A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 56:1267–1269

    Google Scholar 

  12. Fill M, Coronado R, Mickelson JR, Vilven J, Ma J, Jacobson BA, Louis CF (1990) Abnormal ryanodine receptor channels in malignant hyperthermia. Biophys J 50:471–475

    Google Scholar 

  13. Frank JP, Harati Y, Butler IJ, Nelson TE, Scott CI (1980) Central core disease and malignant hyperthermia syndrome. Ann Neurol 7:11–7

    Google Scholar 

  14. Gillard EF, Otsu K, Fujii J, Khanna VK, De Leon S, Derdemezi J, Britt BA, Duff CL, Worton RG, MacLennan DH (1991) A substitution of Cysteine for Arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 11:751–755

    Google Scholar 

  15. Gillard EF, Otsu K, Fujii J, Duff C, DeLeon S, Khanna VK, Britt BA, Worton RG, MacLennan DH (1992) Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics 13:1247–1254

    Google Scholar 

  16. Gronert GA, Mott J, Lee J (1988) Aetiology of malignant hyperthermia. Br J Anaesth 60:253–267

    Google Scholar 

  17. Haan EA, Freemantle CJ, McCure JA, Friend KL, Mulley JC (1990) Assignment of the gene for central core disease to chromosome 19. Hum Genet 86:187–190

    Google Scholar 

  18. Harriman DGF (1988) Malignant hyperthermia myopathy: a critical review. Br J Anaesth 60:309–316

    Google Scholar 

  19. Healy JMS, Heffron JJA, Lehane M, Bradley DG, Johnson K, McCarthy TV (1991) Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers. BMJ 303:1225–1228

    Google Scholar 

  20. Heffron JJA (1998) Malignant hyperthermia: biochemical aspects of the acute episode. Br J Anaesth 60:274–278

    Google Scholar 

  21. Heytens L, Martin JJ, Van de Kelft E, Bossaert LL (1992) In vitro contracture tests in patients with various neuromuscular diseases. Br J Anaesth 68:72–75

    Google Scholar 

  22. Hogan K, Couch F, Powers PA, Gregg RG (1992) A cysteine- for-arginine substitution (R614C) in the human skeletal muscle calcium release channel cosegregates with malignant hyperthermia. Anesth Analg 75:441–448

    Google Scholar 

  23. Kalow W, Britt B, Richter A (1977) The caffeine test of isolated human muscle in relation to malignant hyperthermia. Can J Anaesth 24:678–694

    Google Scholar 

  24. Kausch K, Lehmann-Horn F, Janka M, Wieringa B, Grimm T, Muller CR (1991) Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19. Genomics 10:765–769

    Google Scholar 

  25. Krivosic-Horber R, Krivosic I (1988) Susceptibitily to malignant hyperthermia associated with central core disease. Presse Med 18:828–831

    Google Scholar 

  26. Levitt RC, Nouri N, Jedlicka AE, McKusick VA, Marks AR, Shutack JG, Fletcher JE, Rosenberg H, Meyers DA (1991) Evidence for genetic heterogneity in malignant hyperthermia susceptibility. Genomics 11:543–547

    Google Scholar 

  27. Levitt RC, Olckers A, Meyers S, Fletcher JE, Rosenberg H, Isaacs H, Meyers DA (1992) Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q. Genomics 14:562–566

    Google Scholar 

  28. 28.Lingaraju N, Rosenberg H (1991) Unexplained increases in serum creatine kinase levels: its relation to malignant hyperthermia susceptibility. Anesth Analg 72:702–705

    Google Scholar 

  29. MacLennan DH, Phillips MS (1992) Malignant hyperthermia. Science 256:789–794

    Google Scholar 

  30. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, Britt BA, Worton RG (1990) Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 343:559–561

    Google Scholar 

  31. McCarthy TV, Healy JMS, Heffron JJA, Lehane M, Deufel T, Lehmann-Horn F, Farrall M, Johnson K (1990) Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 343:562–564

    Google Scholar 

  32. Mickelson JR, Gallant EM, Litterer LA, Johnson KM, Rempel WE, Louis CF (1988) Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 263:9310–9315

    Google Scholar 

  33. Mickelson JR, Knudson CM, Kennedy FH, Yang DI, Litterer LA, Rempel WE, Campbell KP, Louis CF (1992) Structural and functional correlates of a mutation in the malignant hyperthermia-susceptible pig ryanodine receptor. FEBS. Lett 301:49–52

    Google Scholar 

  34. Mulley JC, Kozman HM, Phillips HA, Gedeon AK, McCure A, Iles DE, Gregg RG, Hogan K, Couch FJ, MacLennan DH, Haan EA (1993) Refined genetic localization for central core disease. Am J Hum Genet 52:398–405

    Google Scholar 

  35. Ording H (1988) Diagnosis of susceptibility to malignant hyperthermia in man. Br J Anaesth 60:287–302

    Google Scholar 

  36. Poels PIE, Joosten EMG, Sengers RCA, Stadhousers AM, Veerkamp JH, Benders AAGM (1991) In vitro contraction test for malignant hyperthermia in patients with unexplained recurrent rhabdomyolysis. J Neurol Sci 105:67–72

    Google Scholar 

  37. Prelle A, Moggio M, Comi CP, Gallanti A, Checcarelli N, Bresolin N, Ciscato P, Fortunato F, Scarlato G (1992) Congenital myopathy associated with abnormal accumulation of desmin and dystrophin. Neuromusc Disord 2:169–175

    Google Scholar 

  38. Prescott RJ, Roberts SP, Williams G (1992) Malignant hyperpyrexia: a rare cause of postoperative death. J Clin Pathol 45:361–363

    Google Scholar 

  39. Quane KA, Healy JMS, Keating KE, Manning BM, Couch FJ, Palmucci LM, Doriguzzi C, Fagerlund TH, Berg K, Ording H, Bendixen D, Mortier W, Linz U, Muller CR, McCarthy TV (1993) Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nature Genetics 5:51–55

    Google Scholar 

  40. Rosenberg H (1988) Clinical presentation of malignant hyperthermia. Br J Anaesth 66:268–273

    Google Scholar 

  41. Strazis KP, Fox AW (1993) Malignant hyperthermia: a review of published cases. Anesth Analg 77:297–304

    Google Scholar 

  42. Vladutiu G, Hogan K, Saponara I, Tassini L, Conroy J (1993) Carnitine palmitoyl transferase deficiency in malignant hyperthermia. Muscle Nerve 16:485–491

    Google Scholar 

  43. Wedel DJ (1992) Malignant hyperthermia and neuromuscular disease. Neuromusc Disord 2:157–164

    Google Scholar 

  44. Zhang Y, Chen HS, Khanna VK, DeLeon S, Phillips MS, Schapper K, Britt BA, Brownell AKW, MacLennan DH (1993) A mutation in the human ryanodine receptor gene associated with central core disease. Nature Genetics 5:46–50

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Clinica Neurologica, Universita' degli Studi di Milano, Via Francesco Sforza, 35, I-20122, Milan, Italy

    Isabella Moroni, Elda Fabiola, Gonano Giacomo, Pietro Comi, Alessandro Prelle, Andreina Bordoni, Nereo Bresolin & Guglielmo Scarlato

  2. Servizio di Anestesia e Rianimazione —OOT, Via Facciolati 71, I-35127, Padua, Italy

    Vincenzo Tegazzin

Authors
  1. Isabella Moroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elda Fabiola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gonano Giacomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pietro Comi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vincenzo Tegazzin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alessandro Prelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andreina Bordoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nereo Bresolin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Guglielmo Scarlato
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moroni, I., Fabiola, E., Giacomo, G. et al. Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility. J Neurol 242, 127–133 (1995). https://doi.org/10.1007/BF00936884

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00936884

Key words

Search

Navigation